Clinical trial
Anti-Citrullinated SR-A Peptide (Anti-csp)Antibody as a Biomarker for Rheumatoid Arthritis.
NCT07147127 is registered in ClinicalTrials.gov with Walaa sharif Eid Ahmed as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anti-Citrullinated SR-A Peptide (Anti-csp)Antibody as a Biomarker for Rheumatoid Arthritis.
- Lead sponsor
- Walaa sharif Eid Ahmed
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- January 31, 2026
- Completion date
- December 31, 2027
- Enrollment
- 81 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
rheumatoid arthritis (ra)